Press Releases

12345678910
Xceedance Reports 35-50% Efficiency Gains in Insurance Operations Through AI Orchestration
Xceedance said today that AI orchestration is producing measurable efficiency gains in live insurance operations, delivered through Orchestrated Intelligence, its operating model, and IAN, its agent studio for insurance.
By Xceedance · Via Business Wire · September 28, 2026
Simplify Announces It Has Presented an Alternative Proposal to Acquire The Marygold Companies, Inc.
Simplify Asset Management (“Simplify”), a leading provider of Exchange Traded Funds, has submitted a new proposal to the Board of Directors of The Marygold Companies (“Marygold”) offering to acquire 100% of the outstanding shares of common stock of Marygold for $2.25 per share.
By Simplify Asset Management · Via Business Wire · September 28, 2026
H.B. Fuller Appoints R. Jeffrey Bailly to Board of Directors
H.B. Fuller Company (“H.B. Fuller” or “the Company”) (NYSE: FUL), the world’s largest pureplay adhesives company, today announced the appointment of R. Jeffrey Bailly to its Board of Directors, effective immediately. In connection with this appointment, Ruth Kimmelshue will be stepping down from the Board.
By H.B. Fuller Company · Via Business Wire · September 28, 2026
Tempus Receives FDA Clearance for its ECG-MR AI Product Designed to Identify Undiagnosed Mitral Regurgitation
Tempus AI, Inc. (NASDAQ: TEM) today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for Tempus ECG-MR, an AI product that analyzes standard 12-lead resting electrocardiograms (ECGs) to detect signs associated with undiagnosed moderate or severe mitral regurgitation (MR).
By Tempus AI, Inc. · Via Business Wire · September 28, 2026
Aurora Networks and Ziggo Achieve Europe’s First Large-scale Deployment of Unified DOCSIS 4.0 Nodes in a Live Network
Aurora Networks, a business of Vistance Networks (NASDAQ: VISN) and global provider of intelligent network solutions, today announced Europe’s first large-scale deployment of Unified DOCSIS® 4.0 nodes in a live network. Ziggo is the first operator in Europe to bring unified DOCSIS 4.0 nodes into a live network at large scale, setting the pace for next-generation broadband across the continent.
By Vistance Networks · Via Business Wire · September 28, 2026
DermaSensor Launches in Germany with ContraCare’s DERMALYTICA Division, Beginning European Expansion Following Class IIb CE Mark and NHS Collaboration
DermaSensor Inc., a leader in AI-powered skin cancer risk detection technology, today announced the commercial launch of DermaSensor in Germany through a distribution agreement with ContraCare GmbH. The launch represents a significant milestone in DermaSensor’s international expansion following its recent Class IIb CE Mark under the European Union Medical Device Regulation (MDR) and collaboration with the National Health Service (NHS) in the United Kingdom.
By DermaSensor Inc. · Via Business Wire · September 28, 2026
REDLattice, Worldwide Leading Operational Intelligence Platform for the U.S. and its Allies, to Become Public Company
REDL Intermediate Holdings, LLC (together with its subsidiaries, “REDLattice” or the “Company”), the leading operational cyber intelligence platform providing integrated technology solutions to support critical national security and intelligence missions, and Bold Eagle Acquisition Corp. (Nasdaq: BEAG) (“Bold Eagle”), a publicly listed special purpose acquisition company, today announced that they have entered into a definitive agreement for a business combination that would result in REDLattice becoming a publicly traded company listed on the Nasdaq under the ticker symbol “REDL” upon closing of the transaction, which is anticipated around year-end 2026.
By REDLattice · Via Business Wire · September 28, 2026
Teledyne Announces Planned Retirement of Jason VanWees and Appointment of Mary Grace DeForest as Vice President IR and M&A
Teledyne Technologies Incorporated (NYSE:TDY) announced today that Jason VanWees, Vice Chairman, will be retiring from his current position at Teledyne, effective February 1, 2027, at which point he will be age 55. Jason joined Teledyne prior to the company’s spin-off in 1999 and was named Vice Chairman in 2021.
By Teledyne Technologies Incorporated · Via Business Wire · September 28, 2026
LogProstyle Inc. Completes Acquisition of I-FLATZ, Expanding Presence into Japan's Kansai Region
LogProstyle Inc. (NYSE American: LGPS) (the “Company” or “LogProstyle”), headquartered in Minato-ku, Tokyo, Japan, announced today the completion of its previously announced acquisition, first disclosed on August 27, 2026, of 100% of the outstanding shares of I-FLATZ Corporation ("I-FLATZ"), a Kansai-based real estate company engaged in condominium sales, renovation, and leasing. As a result of the transaction, I-FLATZ and its wholly owned subsidiary, LAND-I Co., LTD, have become consolidated subsidiaries of LogProstyle.
By LogProstyle Inc. · Via Business Wire · September 28, 2026
Adobe: U.S. Holiday Shopping Season to Hit Record $275.1 Billion Online, Rising 6.7% YoY
Adobe (Nasdaq: ADBE) released today its online shopping forecast for the 2026 holiday season, covering the period from Nov. 1 to Dec. 31, 2026. Based on Adobe Analytics data, the analysis provides the most comprehensive view into U.S. e-commerce by analyzing direct transactions online. Adobe’s forecast is based on over 1 trillion visits to U.S. retail sites, 100 million SKUs and 18 product categories—more than any other technology company or research organization. Adobe Analytics is part of Adobe CX Enterprise, relied upon by global brands to accelerate Customer Experience Orchestration, connecting data, content and AI to deliver real-time, personalized interactions.
By Adobe · Via Business Wire · September 28, 2026
BGC Group Updates its Outlook for the Third Quarter of 2026
BGC Group, Inc. (Nasdaq: BGC), today announced that it has updated its outlook for the quarter ending September 30, 2026.
By BGC Group, Inc. · Via Business Wire · September 28, 2026
Angel Oak Financial Strategies Income Term Trust Announces Results of 2026 Annual Meeting of Shareholders
Angel Oak Financial Strategies Income Term Trust (NYSE: FINS) (the “Fund”) today announced the final certified voting results from its 2026 Annual Meeting of Shareholders, which was held on September 25, 2026 (the “Annual Meeting”).
HilltopSecurities Launches Sixth Annual Hilltop Hunt
On Oct. 5, 2026, World Teachers’ Day, Hilltop Securities Inc. (HilltopSecurities) will launch its sixth annual virtual Hilltop Hunt, inviting Texas prekindergarten through 12th grade educators to participate in the statewide online Texas trivia competition.
By Hilltop Securities Inc. · Via Business Wire · September 28, 2026
U.S. FDA Accepts sNDA and Grants Priority Review to Bayer’s Lynkuet® (elinzanetant) for a New Indication for the Treatment of Moderate to Severe Vasomotor Symptoms Due to Endocrine Therapy Related to Breast Cancer
Today Bayer announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s supplemental New Drug Application (sNDA) and granted Priority Review designation for Lynkuet® (elinzanetant) under investigation for the treatment of moderate to severe vasomotor symptoms (VMS, also known as hot flashes) in women receiving endocrine therapy for treatment of breast cancer. First approved by the FDA in October 2025 for the treatment of moderate to severe VMS due to menopause, Lynkuet is a dual neurokinin (NK) targeted therapy, neurokinin 1 (NK-1) and neurokinin 3 (NK-3) receptor antagonist.2
By Bayer · Via Business Wire · September 28, 2026
TensorWave Expands Executive Leadership Team as Company Scales AI Infrastructure Operations
TensorWave, the all-AMD AI cloud specializing in high-performance, memory-intensive workloads, today announced four executive appointments as the company continues to scale its infrastructure and operations. Kathleen Simon has been promoted to Chief Financial Officer, Aaron Baker has been promoted to Chief Data Center Officer, and Shawn Novak and JP Buzzell join the company as Chief Revenue Officer and Executive Vice President of Cluster Engineering and Delivery, respectively.
By TensorWave · Via Business Wire · September 28, 2026
SCIEX Expands BioPhase 8800 System Capabilities to Help Laboratories Accelerate Development and Decision-making for Emerging Therapeutics
SCIEX, a Danaher company and leader in life science analytical technologies, today announced new capillary electrophoresis (CE) capabilities for the BioPhase 8800 system that help laboratories accelerate development timelines, strengthen compliance, and integrate more seamlessly into automated workflows. Combining enhanced software, automation connectivity, and expanded analytical support for emerging oligonucleotide-based therapeutics, the updates give scientists greater confidence and flexibility as they move faster from development to decision.
By SCIEX · Via Business Wire · September 28, 2026
Omilia Appoints David Stone as Head of Asia-Pacific
Omilia, a global leader in Self-Learning Agentic CX, today announced the appointment of David Stone as Head of APAC, to lead the company’s go-to-market strategy, sales and partner ecosystem across Asia-Pacific as part of its continued expansion.
By Omilia · Via Business Wire · September 28, 2026
XTEND AI Robotics, Inc. Secures U.S. Patent for NEST Autonomous Base Station, for Persistent Robotic Operations
XTEND AI Robotics, Inc. (NYSE: XTND), a leader in software systems and Physical AI, today announced that the United States Patent and Trademark Office has granted U.S. Design Patent No. D1,147,179 for NEST, XTEND's autonomous base station for persistent robotic operations. The design patent issued on September 8, 2026.
By XTEND AI Robotics, Inc. · Via Business Wire · September 28, 2026
Northern Trust Wealth Management Expands Family Office Solutions Team in New York
Northern Trust Wealth Management is expanding its Family Office Solutions team in New York with the addition of Robert Ludricks III as Managing Director, Northeast Region, and Olof Akesson as Investment Director.
By Northern Trust Wealth Management · Via Business Wire · September 28, 2026
FIS Delivers Real-Time Transaction Clarity to Debit Cardholders
FIS® (NYSE: FIS), a global leader in financial technology, today announced the integration of Spade’s real-time transaction enrichment technology into FIS's debit processing platform. The integration is designed to give FIS debit issuing clients access to richer, more precise merchant data at the transaction level and to help ensure cardholder statements reflect clearer, more recognizable merchant names. The designed result is to reduce unnecessary disputes, enable stronger authorization decisions, and facilitate a more transparent payment experience for cardholders.
National Life Group Adds Four Index Crediting Options to SummitLife Indexed Universal Life (IUL) Insurance, Expanding Choice for Policyholders and Large-Case Opportunities for Financial Professionals
National Life Group announced that two new indexes and four new index crediting options are now available for its SummitLife Indexed Universal Life Insurance product that provides a death benefit of $1 million or more. The updated crediting options allow policyholders greater choice in how their policy value can potentially grow without being directly invested in the market.
By National Life Group · Via Business Wire · September 28, 2026
Liberty Mutual Investments and Thayer Street Partners Form Strategic Partnership
Liberty Mutual Investments (“LMI”), the investment firm for Liberty Mutual Group (“Liberty”), today announced a strategic partnership with Thayer Street Partners (“Thayer Street”), a private investment firm that provides flexible capital solutions to recurring revenue businesses in the financial services, business services, and real estate services sectors. The collaboration will focus on making joint strategic investments in companies spanning real estate and real estate-adjacent services.
By Liberty Mutual Investments · Via Business Wire · September 28, 2026
VeriSIM Life Awarded U.S. Government Agreement to Advance New Approach Methodologies for Drug Development
VeriSIM Life today announced that it has entered into an agreement with the Department of War to advance computational New Approach Methodologies (NAMs) for medical countermeasure development and safety assessment.
By VeriSIM Life · Via Business Wire · September 28, 2026
Tolerance Bio Licenses Clinical-Stage Anti-IL-33 Monoclonal Antibody from Tanabe Pharma to Expand Thymus-Focused Clinical Pipeline
Tolerance Bio, Inc. (“Tolerance Bio” or the “Company”), a biotechnology company focused on preserving, regenerating and modulating thymic function to address immune diseases and extend healthspan, today announced an exclusive license agreement across all indications with Tanabe Pharma Corporation (“Tanabe Pharma”) granting Tolerance Bio worldwide development rights and exclusive commercialization rights outside Japan for MT-2990, now TLB-33, a clinical-stage anti-IL-33 monoclonal antibody. Tanabe Pharma retains commercialization rights in Japan.
By Tolerance Bio, Inc. · Via Business Wire · September 28, 2026
DTCC and iCapital Collaborate to Advance Private Market Infrastructure, Expand Access and Support the Industry’s Next Phase of Growth and Scale
The Depository Trust & Clearing Corporation (DTCC), the premier post-trade market infrastructure for the global financial services industry, and iCapital1, the global fintech company shaping the future of investing, today announced a strategic collaboration to advance the infrastructure supporting private markets.
By iCapital · Via Business Wire · September 28, 2026
KnowBe4 Launches New Integration with Workday Learning to Streamline Security Awareness and Compliance Training
KnowBe4, a cybersecurity company specializing in digital workforce security, securing both AI agents and humans, today announced it has launched KnowBe4 for Workday Learning, a Workday Cloud Connect for Learning (CCL) integration. The integration enables organizations to deliver KnowBe4 security awareness and compliance training seamlessly through Workday Learning while automatically synchronizing records to reduce administrative overhead. As a Workday Innovation Partner, KnowBe4 has achieved the Workday Design Approved Integration badge.
By KnowBe4 · Via Business Wire · September 28, 2026
Fincadia Advisors’ Investment Funds Invest $50 Million in Positron AI’s $875 Million Series C and C-1 Financing
FCP Venture X LLC Series XV and FCP Venture X QP LLC Series XXI (together, the “Series”), each a separate series of a Delaware series limited liability company advised by Fincadia Advisors LLC (“Fincadia Advisors”), an investment adviser registered with the Securities and Exchange Commission, today announced a $50 million investment in Positron AI, as part of the company’s $875 million Series C and C-1 financing at a $5 billion post-money valuation.
By Fincadia Advisors · Via Business Wire · September 28, 2026
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 21, 2026
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the third quarter 2026 before the market opens on Wednesday, October 21, 2026, and will hold a conference call on the same day at 7:00 a.m. ET. During the call, the company will discuss its financial performance, as well as future expectations.
By Thermo Fisher Scientific Inc. · Via Business Wire · September 28, 2026
Masco Corporation Announces Date for Earnings Release and Conference Call for 2026 Third Quarter
Masco Corporation (NYSE: MAS) will hold a conference call regarding its 2026 third quarter results on Wednesday, October 28 at 8:00 a.m. ET, hosted by President and Chief Executive Officer, Jon Nudi. To join, dial (585) 542-9983 or (833) 461-5787 and enter meeting ID 284633590. Please register five to ten minutes before the call begins.
By Masco Corporation · Via Business Wire · September 28, 2026
Aidentyx Announces Official Launch of Next-Generation PODO® AI Framework, Bringing Context-Aware Agentic AI to Manufacturers
Aidentyx today announced the official launch of the next generation of its PODO® AI Framework, an agentic AI platform that turns complex industrial data into clear insights, confident decisions, and faster action on the plant floor.
By Aidentyx · Via Business Wire · September 28, 2026
Robbins Geller Rudman & Dowd LLP Announces Proposed Settlement in the WEBTOON Securities Litigation
The following statement is being issued by Robbins Geller Rudman & Dowd LLP regarding the WEBTOON Securities Litigation:
By Robbins Geller Rudman & Dowd LLP · Via Business Wire · September 28, 2026
Range Adds Apex Fintech Solutions to Power Next Phase of Growth
Apex Fintech Solutions Inc. (“Apex”), the infrastructure powering modern investing, and Range Finance, a financial platform built for high-income households, today announced a strategic alliance to power Range's next phase of growth. Through this collaboration, Range will leverage Apex's cloud-native AscendOS™ platform to deliver an enhanced wealth management experience for its members, including self-directed account openings and transfers, while laying the foundation to expand into broker-dealer services.
By Apex Fintech Solutions Inc. · Via Business Wire · September 28, 2026
Harvard Ave Acquisition Corporation and OAG International Ltd Announce Definitive Business Combination Agreement
New York, Sept. 28, 2026 (GLOBE NEWSWIRE) -- Harvard Ave Acquisition Corporation (“HAVA”) (Nasdaq: HAVA), a publicly traded special purpose acquisition company, and OAG International Ltd (“OAG”), a global provider of specialized pipeline construction and integrity services for critical onshore and offshore energy infrastructure, today jointly announced that they have entered into a definitive business combination agreement (the “Business Combination Agreement”). Upon completion of the business combination between HAVA and OAG and related transactions pursuant to the Business Combination Agreement (collectively, the “Proposed Transactions”), OAG Pipeline Technologies Inc., a Cayman Islands exempted company newly formed for the purpose of effecting the Proposed Transactions (the “Combined Company” or “PubCo”), is expected to be listed on The Nasdaq Stock Market LLC (“Nasdaq”).
By Harvard Ave Acquistion Corp · Via GlobeNewswire · September 28, 2026
Fobi AI (TSXV: FOBI) Issues Corporate Update on Business Transition; Schedules Live Product Demo for October 7
Vancouver, British Columbia, Sept. 28, 2026 (GLOBE NEWSWIRE) -- Fobi AI Inc. (TSXV: FOBI) (Pink: FOBIF) (the “Company” or “Fobi”) today provided a corporate update on its recently introduced Fobi Flywheel, its active legacy businesses and its intended strategic focus for the balance of 2026.
By Fobi AI Inc. · Via GlobeNewswire · September 28, 2026
Allarity Therapeutics Expands Laboratory Capabilities to Include Proteomics and Cell Line Research
        - Expanded laboratory capabilities support deeper mechanism-of-action research for stenoparib - New proteomics and cell line capabilities will broaden Allarity’s research capabilities to enable external partnerships
By Allarity Therapeutics, Inc. · Via GlobeNewswire · September 28, 2026
Lantheus Announces First Patient Dosed in SPARROW Phase 2/3 Registrational Trial in Prostate Cancer
Study advances development of Lantheus' investigational GRPR-targeted PET imaging program for prostate cancer
By Lantheus Holdings, Inc. · Via GlobeNewswire · September 28, 2026
Astro Digital, Premier Builder of Satellites for Commercial, Civil and Defense Applications, to Become Public Through Merger with Proem Acquisition Corp I
Since 2018, Astro Digital has delivered nearly 40 satellites across 16 mission types for more than 30 customers, including NASA, the Department of Defense, Boeing, and Sony.
By Proem Acquisition Corp I · Via GlobeNewswire · September 28, 2026
Adhesion Wealth Launches Custom Model Solutions for RIAs
New solution combines Fidelity Investment model portfolio expertise with Adhesion’s UMA technology to deliver tailored, multi-sleeve portfolios at scale- with no Adhesion platform or Tax Management Services fees 
By AssetMark, Inc. · Via GlobeNewswire · September 28, 2026
4DMT Advances 4D-150 into Phase 3 for Second Large Market Retina Indication with Initiation of 4SIGHT in DME
EMERYVILLE, Calif., Sept. 28, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT; 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today announced that the first patients have been enrolled across multiple sites in the 4SIGHT Phase 3 clinical trial evaluating 4D-150 for the treatment of diabetic macular edema (DME). The Company also reported 2-year data from the SPECTRA clinical trial.
By 4D Molecular Therapeutics, Inc. · Via GlobeNewswire · September 28, 2026
COMSTOCK ANNOUNCES SIGNING OF FRAMEWORK AGREEMENT FOR $1.65 BILLION STRATEGIC PARTNERSHIP WITH SOCAR
FRISCO, TX, Sept. 28, 2026 (GLOBE NEWSWIRE) -- Comstock Resources, Inc. (NYSE and NYSE Texas: CRK) ("Comstock" or the "Company") announced today that in conjunction with the Azerbaijan International Investment Forum, Comstock and SOCAR entered into a Framework Agreement memorializing the previously announced strategic partnership and SOCAR's $1.65 billion investment in the Haynesville Shale, North America’s premier natural gas basin with close proximity to the Gulf of America's LNG export facilities. The Framework Agreement memorializes both parties' mutual commitment to negotiate and execute a definitive purchase and sale agreement consistent with the previously announced letter of intent related to the $1.65 billion strategic partnership. The definitive purchase and sale agreement is anticipated to be signed no later than October 31, 2026, and the transaction is expected to be closed by the end of 2026.  
By Comstock Resources, Inc. · Via GlobeNewswire · September 28, 2026
NeOnc Technologies Announces FDA End of Phase 1 Meeting for NEO212
November 17 meeting will address Phase 2 study design and potential regulatory pathways
By NeOnc Technologies Holdings, Inc. · Via GlobeNewswire · September 28, 2026
ROC Secures $64.3 Million U.S. Department of Justice Contract for Digital Evidence Technology
Eight-year DOJ contract establishes strategic beachhead for ROC Evidence
By ROC · Via GlobeNewswire · September 28, 2026
Callio Therapeutics Appoints Chris Hassig, PhD, as Chief Scientific Officer
Industry veteran brings more than two decades of oncology drug discovery leadership to advance Callio's dual-payload ADC pipeline
By Callio Therapeutics · Via GlobeNewswire · September 28, 2026
DFDV Grows SOL Treasury 10% in Just 6 Weeks, Surpassing 2.5 Million SOL Held
Continued purchases and organic accumulation drive approximately 10% growth in SOL holdings since the Company’s August 12 Earnings Update
By DeFi Development Corporation · Via GlobeNewswire · September 28, 2026
ALX Oncology Announces Nature Medicine Publication of ASPEN-06 Phase 2 Clinical Data Demonstrating Strong Responses and Durable Clinical Benefit with Evorpacept in HER2-Positive Gastric Cancer
Achieved 40.3% ORR with evorpacept plus trastuzumab, ramucirumab and paclitaxel versus 26.6% for control, with response rates increasing to 63.6% versus 23.1% among patients with high CD47 expression and retained HER2-positive disease
By ALX Oncology · Via GlobeNewswire · September 28, 2026
Tim Swiat Joins Monarch Private Capital as Director of Placement, Colorado
Experienced banking and business development executive expands Monarch’s relationships across Colorado, the Rocky Mountain region and the Upper Midwest
By Monarch Private Capital · Via GlobeNewswire · September 28, 2026
Curonix Announces Published PNS IMPACT Clinical Study Showing Freedom® Peripheral Nerve Stimulator (PNS) System is Associated with Reductions in Pain Scores, Opioid Use and Overall Patient Burden
POMPANO BEACH, Fla., Sept. 28, 2026 (GLOBE NEWSWIRE) -- Curonix LLC, a leading medical technology company dedicated to relieving chronic pain, today announced the publication of a milestone study, Peripheral Nerve Stimulation for Intractable Chronic Pain: Real-World Clinical Outcomes, Utilization, and Economic Impact (PNS IMPACT Study), in Pain Physician. The study evaluated the clinical outcomes and broader economic impact of the Freedom® Peripheral Nerve Stimulator (PNS) System across a large patient cohort, providing comprehensive insights into its value for patients, providers, and the healthcare system.
By Curonix LLC · Via GlobeNewswire · September 28, 2026
Phillips Edison & Company Inc. Invites You to Join Its Third Quarter 2026 Earnings Conference Call
CINCINNATI, Sept. 28, 2026 (GLOBE NEWSWIRE) -- Phillips Edison & Company, Inc. (Nasdaq: PECO) (“PECO” or the “Company”), one of the nation’s largest owners and operators of high-quality, grocery-anchored neighborhood shopping centers, will announce its Third Quarter 2026 earnings results on Monday, October 26, 2026, after the market closes. PECO’s earnings release and financial supplement will be posted on the Investor Relations section of the Company’s website at https://investors.phillipsedison.com/. Chairman and Chief Executive Officer Jeff Edison, President Bob Myers and Chief Financial Officer John Caulfield will host an earnings conference call, which will also be webcast, on Tuesday, October 27, 2026, at 12:00 p.m. ET.
By Phillips Edison & Company, Inc. · Via GlobeNewswire · September 28, 2026
FTI Consulting Expands Italy Restructuring and Turnaround Capabilities With Senior Appointments
Jacopo Barontini and Fulvio Taglialatela Strengthen Support for Italian Companies and Creditors Facing Complex Restructuring, Turnaround and Cross-Border Challenges
By FTI Consulting, Inc. · Via GlobeNewswire · September 28, 2026
Lucasys Announces The Gathering, Its Inaugural Customer Conference
Lucasys brings together customers, employees and partners at Nobu Hotel Atlanta, March 21-23, 2027, for three days of practitioner-led sessions, product roadmap insights and time with the team behind the Lucasys Income Tax Suite
By Lucasys · Via GlobeNewswire · September 28, 2026